NOX4 and heart disorder: In the present review, we focus on preclinical studies involving models of cardiac diseases in which NOX4 expression was specifically induced and/or repressed using transgenic approaches, adenoviruses or chemicals, to demonstrate causality between upregulation of NOX4 and cardiac effects, either deleterious or beneficial.